Bioinformatic screening and experimental analysis identify SFRP1 as a prognostic biomarker for tongue squamous cell carcinomas

被引:1
作者
Yu, Mei [1 ]
Wu, Guiyun [3 ]
Chen, Yiyang [1 ]
Wang, Hongtao [1 ]
Gao, Yongbo [4 ]
Wang, Anxun [2 ]
机构
[1] Guangzhou Women & Childrens Med Ctr, Dept Oral & Maxillofacial Surg, Guangzhou, Peoples R China
[2] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Oral & Maxillofacial Surg, Guangzhou, Peoples R China
[3] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Anesthesiol, Guangzhou, Peoples R China
[4] Longgang Cent Hosp Shenzhen, Dept Stomatol, Shenzhen, Peoples R China
关键词
Tongue squamous cell carcinoma (TSCC); Differentially expressed genes (DEGs); Bioinformatics; Prognosis; Biomarker; SFRP1; IMATINIB MESYLATE; TARGETING SFRP1; POOR-PROGNOSIS; CANCER CELLS; PROLIFERATION; PROMOTES; EXPRESSION; METASTASIS; GENE; NECK;
D O I
10.1016/j.archoralbio.2019.104587
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Objective: To provide a prognostic biomarker and a potential therapeutic target for tongue squamous cell carcinoma (TSCC). Design: Screening the prognostic genes of TSCC by bioinformatics, and verifying the correlation between the above genes and the prognosis of TSCC by experiments. Results: Twenty-four common differentially expressed genes (DEGs) between TSCC and the corresponding normal tissues were screened from four sets of TSCC functional gene expression series in Gene Expression Omnibus (GEO) datasets. Further bioinformatics research based on the data from The Cancer Genome Atlas (TCGA), Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) indicate that the low expression of SFRP1 might be correlated with poor prognosis of TSCC patients. By colony formation assay, reverse transcription polymerase chain reaction (RT-PCR), western blotting, immunohistochemical staining, flowcytomerry, lentivirus transfection and animal experiments, it was confirmed that the low level of SFRP1 expression correlated with poor prognosis of TSCC patients. Conclusion: This study identified SFRP1 as a novel prognostic biomarker and a potential therapeutic target for TSCC.
引用
收藏
页数:7
相关论文
共 53 条
  • [1] Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta
    Apperley, JF
    Gardembas, M
    Melo, JV
    Russell-Jones, R
    Bain, BJ
    Baxter, J
    Chase, A
    Chessells, JM
    Colombat, M
    Dearden, CE
    Dimitrijevic, S
    Mahon, FX
    Marin, D
    Nikolova, Z
    Olavarria, E
    Silberman, S
    Schultheis, B
    Cross, NCP
    Goldman, JM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (07) : 481 - 487
  • [2] RETRACTED: MicroRNA-27a Promotes the Proliferation and Invasiveness of Colon Cancer Cells by Targeting SFRP1 through the Wnt/β-Catenin Signaling Pathway (Retracted article. See vol. 55, pg. 140, 2021)
    Ba, Sang
    Xuan, Yi
    Long, Zi-Wen
    Chen, Hai-Yong
    Zheng, Shu-Sen
    [J]. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2017, 42 (05) : 1920 - 1933
  • [3] Bello IO, 2010, ORAL ONCOL, V46, P630, DOI 10.1016/j.oraloncology.2010.06.006
  • [4] Byers RM, 1998, HEAD NECK-J SCI SPEC, V20, P138, DOI 10.1002/(SICI)1097-0347(199803)20:2<138::AID-HED7>3.0.CO
  • [5] 2-3
  • [6] Expression and prognostic value of SFRP1 and β-catenin in patients with glioblastoma
    Chang, Liang
    Lei, Xuhui
    Qin, Yu
    Zeng, Guangchun
    Zhang, Xuexin
    Jin, Hua
    Wang, Chao
    Wang, Xin
    Su, Jun
    [J]. ONCOLOGY LETTERS, 2016, 11 (01) : 69 - 74
  • [7] Obesity-associated miR-27a upregulation promotes hepatocellular carcinoma metastasis through suppressing SFRP1
    Chen, Yang
    Zhang, Fan
    Zhao, Yawei
    He, Kan
    Zheng, Xiao
    Pan, Yue
    Shao, Dan
    Shang, Pei
    Yang, Yongsheng
    Zhang, Dan
    Xie, Yingjun
    Yao, Xiaoxiao
    Chen, Li
    Li, Jing
    Zhang, Xuewen
    [J]. ONCOTARGETS AND THERAPY, 2018, 11 : 3281 - 3292
  • [8] Dicer promotes tumorigenesis by translocating to nucleus to promote SFRP1 promoter methylation in cholangiocarcinoma cells
    Cheng, Wenlong
    Qi, Yongqiang
    Tian, Li
    Wang, Bing
    Huang, Wenhua
    Chen, Yongjun
    [J]. CELL DEATH & DISEASE, 2017, 8 : e2628 - e2628
  • [9] Downregulation of HP1α suppresses proliferation of cholangiocarcinoma by restoring SFRP1 expression
    Cheng, Wenlong
    Tian, Li
    Wang, Bing
    Qi, Yongqiang
    Huang, Wenhua
    Li, Hongbo
    Chen, Yong-Jun
    [J]. ONCOTARGET, 2016, 7 (30) : 48107 - 48119
  • [10] Davaadorj M, 2016, ANTICANCER RES, V36, P659